ITCI (intracellulartherapies.com) Bozor qiymatining balans qiymatiga nisbati
Intra-Cellular Therapies (ITCI) kompaniyasining narxning buxgalteriya qiymatiga nisbati grafigi aktivlarda xavfsizlik zaxirasini namoyish etadi, bunda 12.14 belgisi ushbu parametrni xarakterlaydi. Intra-Cellular Therapies (ITCI) Caplyta preparatini depressiya terapiyasiga joriy qilish orqali yagona mahsulotga bo'lgan bog'liqligini kamaytirmoqda. Daromadlar o'sishi sug'urta dasturlarining kengayishi va yangi tadqiqotlarga asoslangan. Bipolyar buzilish va shizofreniya dori vositalariga bo'lgan talab biznesni defensiv aktivga aylantiradi va uni iqtisodiy sharoitlardan mustaqil qiladi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ITCI_-_Intra-Cellular-Therapies_-_Capitalization-to-Book-Value-Ratio "ITCI Intra-Cellular Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 13.04.2025) | 👁️GURU.Markets👁️")
Intra-Cellular Therapies (ITCI) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:Intra-Cellular Therapies Inc. (ITCI)
Fundamental biznesni baholash bozor shovqinini aktivlarning haqiqiy qiymatidan ajratishni talab qiladi. Ushbu koeffitsient emitentning bozor qiymatini uning balans qiymati bilan solishtirib, kapitalning haddan tashqari yuqori yoki past baholanganlik darajasini aniqlaydi. Kompaniyaning joriy P/B koeffitsiyentini tahlil qilish orqali investor o'sish potentsiali uchun bozor premiumini aniqlashi mumkin. Intra-Cellular Therapies (ITCI) uchun ushbu metrika Caplyta dori vositasining tijorat miqyosidagi kengayishiga nisbatan bozor kutganlarini aks ettiradi. Psixiatriyadagi terapevtik ko'rsatmalarning kengayishi bevosita kapitalizatsiya qilinmoqda, bu esa balans qiymati va birja narxi orasidagi farqni yanada oshirmoqda.
Toʻgʻridan-toʻgʻri raqobatchilar
Biogen Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|NBIX (neurocrine.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AMLX: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi TRVI|Bozor qiymatining balans qiymatiga nisbati Praxis Precision Medicines, Inc. PRAX|Kapitallashuvning balans qiymatiga nisbati Anavex AVXL|Kapitallashuvning sof aktivlarga nisbati CeriBell Corp (CBLL)|Prothena - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Alector Therapeutics (ALEC)|ANNX - Balans qiymatiga nisbatan bozor qiymati|OMER: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Neurogene Inc|AC Immune Corp - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining xususiy kapitalga nisbati Voyager Corp|Bozor kapitallashuvining balans qiymatiga nisbati NMRA (Neumora Therapeutics)|Kapitallashuvning sof aktivlarga nisbati scilexholding.com (SCLX)|TVGN: Bozor kapitallashuvining balans qiymatiga nisbati|Alpha Cognition Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|CGTX - Bozor qiymatining balans qiymatiga nisbati|IKT: Bozor qiymatining balans qiymatiga nisbati|Cassava Sciences, Inc. (SAVA) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Assertio|COYA (Coya Therapeutics Inc) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VTGN|Bozor qiymatining balans qiymatiga nisbati Ovid Therapeutics Inc. (OVID)|Bozor qiymatining balans qiymatiga nisbati Acumen Pharmaceuticals, Inc (ABOS)|Bozor kapitallashuvining balans qiymatiga nisbati CRVO (CervoMed Inc.)|Alterity Therapeutics Ltd. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Clene Nanomedicine (CLNN)|PepGen Inc. (PEPG) - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Jupiter Neurosciences JUNS|Balans qiymatiga nisbatan bozor qiymati Relmada Corp|Annovis Bio, Inc. (ANVS) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Grace Tx|Firefly Neuroscience (AIFF) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati anewmeds.com (KLTO)|NRSN: Bozor kapitallashuvining balans qiymatiga nisbati|Reviva Pharmaceuticals, Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati MetaVia, Inc. (MTVA)|NRXS - Balans qiymatiga nisbatan bozor qiymati|HSDT: Bozor kapitallashuvining balans qiymatiga nisbati|PASG (Passage Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Neuphoria Therapeutics, Inc. NEUP|Sof aktivlarga nisbatan bozor kapitallashuvi Minerva|ATHA (Athira Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi addextherapeutics.com (ADXN)|ALZN: Bozor kapitallashuvining balans qiymatiga nisbati|Cyclerion Therapeutics Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati PTIX (Protagenic)|KTTA - Balans qiymatiga nisbatan bozor kapitallashuvi|cortigent.com - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi avenuetx.com|BrainStorm Cell Therapeutics (BCLI) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Cara Therapeutics Inc.|Bozor kapitallashuvining balans qiymatiga nisbati CHRO (Chromocell Therapeutics Corporation)|Kapitallashuvning sof aktivlarga nisbati eliemtx.com (ELYM)|Bozor kapitallashuvining balans qiymatiga nisbati LBPH|marinuspharma.com - Balans qiymatiga nisbatan bozor kapitallashuvi|NKGen Biotech (NKGN) - Bozor qiymatining balans qiymatiga nisbati|NRBO - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SAGE|Bozor qiymatining balans qiymatiga koeffitsiyenti Synaptogenix, Inc|TRVN (Trevena, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VIGL|Anew Medical, Inc. (WENA) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CERE (Cerevel Therapeutics Inc)